• News
  • Business
  • Opportunities
  • Articles & Resources
  • Spotlight
  • Views
    • Interviews
    • Opinions
  • MSME Jobs
  • More
    • Africa
    • World
  • webmail
  • Terms of Use
MSME Africa
  • News
  • Business
  • Opportunities
  • Articles & Resources
  • Spotlight
  • Views
    • Interviews
    • Opinions
  • MSME Jobs
  • More
    • Africa
    • World
  • webmail
  • Terms of Use
No Result
View All Result
  • News
  • Business
  • Opportunities
  • Articles & Resources
  • Spotlight
  • Views
    • Interviews
    • Opinions
  • MSME Jobs
  • More
    • Africa
    • World
  • webmail
  • Terms of Use
No Result
View All Result
MSME Africa
No Result
View All Result

Jawa International Launches Facility in Lagos, Creates 700+ Jobs, Boosts Local Pharmaceutical Production

Olusola Blessing by Olusola Blessing
December 18, 2024
in Business, News
0
Jawa International Launches Facility in Lagos, Creates 700+ Jobs, Boosts Local Pharmaceutical Production
Share

Jawa International has created over 700 jobs with the launch of Beta Lactam Pharmaceutical Manufacturing Facility in Lagos, Nigeria, says Dr. Muhammed Ali Pate, the Coordinating Minister for Health. In a statement, Dr. Pate described the launch as a pivotal moment in Nigeria’s journey toward medical industrialization.

He emphasized that this achievement is not just a milestone for the pharmaceutical sector but a decisive step in our collective efforts to unlock Nigeria’s health sector value chain.

“This marks another step forward in the country’s path to medical industrialization. The commissioning of this facility proves that progress is not just possible—it is inevitable.”   

“The Beta Lactam facility stands as a testament to what can be achieved when government policies align with private sector vision and perseverance,” he remarked on his X handle.

The Coordinating Minister for Health stressed that the importance of this development cannot be overstated.

“For too long, Nigeria has relied heavily on imports for even the most basic healthcare commodities. This facility brings us closer to breaking that dependence. By producing essential antibiotics like Amoxicillin-Clavulanic Acid locally, we not only ensure supply chain security but also reduce costs for consumers, particularly the most vulnerable populations,” he explained.

Dr. Pate stated that over 700 Nigerians have already secured quality employment through the facility. He explained that this job creation is helping to improve household incomes and uplift local communities.

“This is the tangible impact of industrialization in action—job creation, retained earnings, and increased production capacity that will serve both Nigeria and the African continent,” he said.

Dr. Pate also emphasized President Bola Ahmed Tinubu’s commitment to transforming the health sector from a consumption-driven model to one that creates jobs, protects economic value, and strengthens domestic manufacturing capacity.

He further aligned this development with the Executive Order signed by the President in June, aimed at stimulating domestic manufacturing of pharmaceuticals, test kits, medical textiles, and consumables. The order also incorporates market-shaping interventions to prioritize local manufacturers in government procurement.

Despite the challenges faced in implementation, Dr. Pate expressed confidence that the policy is now poised to deliver on its objectives.

“While challenges have been addressed collaboratively with stakeholders, I am pleased to note that the policy is positioned to deliver its intended results,” he said.

Dr. Pate commended the indefatigable work of Dr. Abdu Mukhtar, Coordinator of the Pharmaceutical and Value Chain Administration, and his dedicated team, emphasizing that their relentless efforts have been instrumental in advancing key initiatives to unlock the healthcare value chain and ensuring that industrialization in health moves from policy to action.

 

Commitment to supporting the pharmaceutical industry

The Coordinating Minister for Health further stated that the government’s commitment remains clear.

 

“We will continue to support the pharmaceutical industry through policies that promote industrialization, job creation, and economic growth. 

 

“Regulators such as the National Agency for Food and Drug Administration and Control (NAFDAC) and the Pharmacy Council of Nigeria registry have been tasked with enhancing efficiency and effectiveness in their operations.  

“Our goal is to ensure a regulatory environment that is robust and facilitative, one that encourages industry to thrive without undue constraints,” he said.

In closing, Dr. Pate extended his congratulations to the Federation of Nigerian Pharmaceutical Industry for their hard work in establishing and expanding manufacturing plants.

He also congratulated Jawa International, its staff, and management, particularly the Managing Director, Chief Varkey Verghese, MFR, and Barrister Boss Mustapha, on their significant achievement.

“Together, we are building a health sector that improves health outcomes for our citizens while driving economic value for Nigeria,” he concluded

Post Views: 31
Share

Related Posts:

  • Africa must prepare for the inevitability of a global food crisis - Akinwumi Adesina
    Overcoming Binding Constraints to Competitive…
  • Brazilian Entity Invests $240 Million in Nigerian Generic Drug Manufacturing Plant
    Brazilian Entity Invests $240 Million in Nigerian…
  • President Tinubu Signs N150,000 Grant for Each MSME Clinics Participants to Boost Local Healthcare Production
    President Tinubu Signs Executive Order to Boost…
  • MSME Africa Unveils Top 50 Remarkable MSME Founders 2023, Awards them $25,000 in Media Credits
    MSME Africa Unveils Top 50 Remarkable MSME Founders…
  • GTBank to give 1,000 Women Free Health Coverage for one Year; Calls for Nominations
    GTBank to give 1,000 Women Free Health Coverage for…
  • The African Continental Free Trade Area (AfCFTA); A key to mitigate the effects of the COVID-19 pandemic in Africa
    The African Continental Free Trade Area (AfCFTA); A…
Tags: Jawa InternationalMSMEsPharmaceutical ManufacturingSMEs
Previous Post

Five Multinationals Exit Nigeria as Economic Challenges Persist

Next Post

Nigeria Allocates N47 Billion to Boost Agricultural and Medical Education

Next Post
Nigeria Allocates N47 Billion to Boost Agricultural and Medical Education

Nigeria Allocates N47 Billion to Boost Agricultural and Medical Education

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result
Join MSME on Whatsapp
Subscribe To Our Newsletter
Enter your email to receive a weekly round-up of our best posts. Learn more!
icon
By subscribing, you agree with our privacy policy and our terms of service.

Recent Posts

  • Meta’s Exit Threat Puts Over Half of Nigerian MSMEs at Risk
  • Poor Infrastructure, Logistics Hinder African SMIs from Benefiting Fully from AfCFTA
  • JA Africa and Boeing Launch Youth-Focused STEM and Entrepreneurship Programmes in Nigeria, Togo
  • Nigeria’s Business Confidence Rises to +12.29 in April, but Structural Constraints Persist
  • OPay’s Security Questions Are Back and Smarter Than Ever

Recent Comments

  • 10 Reasons Why SMEs Should Invest in Video Marketing - MSME Africa on How to Create Viral Videos for Social Media in 2024
  • link alay4d on 5 Nigerian-based Companies Providing Accelerator Programs for Startups in 2024
  • Damilare Oladeji on Nigerian Government Agencies that Support Entrepreneurship in 2024
  • situs alay4d on 50 Best Tools to Boost Your Productivity as an Entrepreneur in 2024
  • Otabor Osayomore Blessing on Ultimate 2024 Guide to the Top Business Enabling Cities for Startup Founders and Entrepreneurs in Nigeria
  • About us
  • Advertise with us
  • Contact Us
  • Home
  • News
  • Newsletter
  • Submit News
  • Terms of Use

© 2023 MSME Africa - All rights reserved.

No Result
View All Result
  • About us
  • Advertise with us
  • Contact Us
  • Home
  • News
  • Newsletter
  • Submit News
  • Terms of Use

© 2023 MSME Africa - All rights reserved.